BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8586805)

  • 1. A comparison of the effect of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism on the structural changes associated with hypertension in rat small arteries.
    Shaw LM; George PR; Oldham AA; Heagerty AM
    J Hypertens; 1995 Oct; 13(10):1135-43. PubMed ID: 8586805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
    Brilla CG; Matsubara L; Weber KT
    Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
    Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
    Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy.
    Rizzoni D; Muiesan ML; Porteri E; Castellano M; Zulli R; Bettoni G; Salvetti M; Monteduro C; Agabiti-Rosei E
    J Hypertens; 1997 Feb; 15(2):197-204. PubMed ID: 9469796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
    Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Kai T; Horiuchi M
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S360-2. PubMed ID: 9072428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional salutary effects of the combination of exercise training and an angiotensin-converting enzyme inhibitor on the left ventricular function of spontaneously hypertensive rats.
    Ziada AM
    J Hypertens; 2009 Jun; 27(6):1309-16. PubMed ID: 19462500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cardiovascular hypertrophy and cardiac baroreflex function in spontaneously hypertensive and stroke-prone rats.
    Minami N; Head GA
    J Hypertens; 1993 May; 11(5):523-33. PubMed ID: 8390524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats : effects of angiotensin receptor antagonism and converting enzyme inhibition.
    Intengan HD; Thibault G; Li JS; Schiffrin EL
    Circulation; 1999 Nov; 100(22):2267-75. PubMed ID: 10578002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
    J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
    Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
    Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
    Brilla CG; Janicki JS; Weber KT
    Circulation; 1991 May; 83(5):1771-9. PubMed ID: 1850668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
    Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of arterial structural alterations with verapamil and trandolapril and consequences for mechanical properties in spontaneously hypertensive rats.
    Koffi I; Lacolley P; Kirchengaast M; Pomiès JP; Laurent S; Benetos A
    Eur J Pharmacol; 1998 Nov; 361(1):51-60. PubMed ID: 9851541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of cardiac, but not vascular, hypertrophy in the cardiac baroreflex deficit in spontaneously hypertensive and stroke-prone rats.
    Head GA; Minami N
    Am J Med; 1992 Apr; 92(4B):54S-59S. PubMed ID: 1533747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of candesartan cilexetil and enalapril on structural alterations and endothelial function in small resistance arteries of spontaneously hypertensive rats.
    Rizzoni D; Porteri E; Bettoni G; Piccoli A; Castellano M; Muiesan ML; Pasini G; Guelfi D; Rosei EA
    J Cardiovasc Pharmacol; 1998 Nov; 32(5):798-806. PubMed ID: 9821855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
    Pu Q; Larouche I; Schiffrin EL
    Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term angiotensin II type 1 receptor blockade with fonsartan doubles lifespan of hypertensive rats.
    Linz W; Heitsch H; Schölkens BA; Wiemer G
    Hypertension; 2000 Apr; 35(4):908-13. PubMed ID: 10775560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AT1 receptor antagonist treatment caused persistent arterial functional changes in young spontaneously hypertensive rats.
    Gillies LK; Lu M; Wang H; Lee RM
    Hypertension; 1997 Dec; 30(6):1471-8. PubMed ID: 9403569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.